Neo Medical nabs up to $68M in equity funding

Neo Medical, based in Lausanne, Switzerland, has secured up to $68M in equity funding to enhance spine surgery technology.

Led by Gyrus Capital and supported by existing investors, including founders Vincent Lefauconnier and Jonas Larsson, the funds will drive U.S. market expansion, product development, and advancements in their AI-driven AR platform, ADVISE™.

The company aims to increase its market share by leveraging biomechanics and real-time data to improve spine fusion surgery outcomes, reduce environmental impact, and cut healthcare costs.

Since its 2016 launch, Neo Medical has treated approximately 36,000 patients and operates subsidiaries in the U.S., Spain, France, and Germany. Existing investors include institutions like Swisscom Ventures, Verve Ventures, and Credit Suisse Entrepreneur Capital.